XNAS 05 Feb, 2026 11:29 AM (EST)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Chelsea Sierra Voss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2026 | 212,500 | 212,500 | - | - | Employee Stock Option (Right to Buy) | |
| Chelsea Sierra Voss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2026 | 212,500 | 214,900 | - | 0 | Common stock | |
| Chelsea Sierra Voss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2026 | 25,000 | 239,900 | - | 0 | Common stock | |
| Bill Joe White | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2025 | 22,839 | 25,024 | - | 0 | Common stock | |
| Stephen Friscia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2025 | 22,839 | 25,000 | - | 0 | Common stock | |
| Joshua Nathaniel Silverman | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2025 | 91,356 | 100,029 | - | 0 | Common stock | |
| Mitchell Glass | Director, Director, Chief Medical Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2025 | 11,420 | 12,500 | - | 0 | Common stock | |
| Stephen Friscia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2025 | 2,161 | 2,161 | - | 0 | Common stock | |
| Mitchell Glass | Director, Director, Chief Medical Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2025 | 1,080 | 1,080 | - | 0 | Common stock | |
| Joshua Nathaniel Silverman | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2025 | 8,644 | 8,673 | - | 0 | Common stock | |
| Bill Joe White | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2025 | 2,161 | 2,185 | - | 0 | Common stock | |
| Ian Rhodes | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 25,000 | 25,000 | - | - | Employee Stock Option (Right to Buy) | |
| Mitchell Glass | Director, President, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 125,000 | 125,000 | - | - | Employee Stock Option (Right to Buy) | |
| Paul Rivard | Chief Legal Officer | Purchase of securities on an exchange or from another person at price $ 1.11 per share. | 24 Aug 2023 | 150,000 | 400,000 | - | 1.1 | 166,500 | Common stock |
| Paul Rivard | Chief Legal Officer | Purchase of securities on an exchange or from another person at price $ 1.12 per share. | 17 Aug 2023 | 25,000 | 250,000 | - | 1.1 | 28,080 | Common stock |
| Paul Rivard | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 150,000 | 150,000 | - | - | Employee Stock Option (Right to Buy) | |
| Christopher C. Chapman | Director, President, Chief Med. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 300,000 | 300,000 | - | - | Employee Stock Option (Right to Buy) | |
| Craig Eagle | Director | 07 Jun 2023 | 475,000 | 475,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Adam Kaplin | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 150,000 | 150,000 | - | - | Employee Stock Option (Right to Buy) | |
| Christopher Charles Schreiber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 150,000 | 150,000 | - | - | Employee Stock Option (Right to Buy) | |
| Bill Joe White | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 150,000 | 150,000 | - | - | Employee Stock Option (Right to Buy) | |
| Joshua Nathaniel Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 200,000 | 200,000 | - | - | Employee Stock Option (Right to Buy) | |
| Jude Uzonwanne | Director | 07 Jun 2023 | 150,000 | 150,000 | - | - | Employee Stock Option (Right to Buy) | ||
| Christopher C. Chapman | Director, President, Chief Med. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 750,000 | 750,000 | - | - | Employee Stock Option (Right to Buy) | |
| Paul Rivard | EVP of Operations, GC | Purchase of securities on an exchange or from another person at price $ 1.53 per share. | 08 Dec 2022 | 10,000 | 225,000 | - | 1.5 | 15,300 | Common stock |
| Robert C. Schroeder | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.94 per share. | 16 Apr 2021 | 14,694 | 29,236 | - | 4.9 | 72,588 | Common Stock |
| Robert C. Schroeder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2021 | 43,930 | 0 | - | - | Restricted Stock Units | |
| Robert C. Schroeder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2021 | 43,930 | 43,930 | - | - | Common Stock |